World PulseNow
Newsletter

Novo Nordisk’s ‘lottery ticket’: can obesity drugs help treat Alzheimer’s?

Financial Times•Monday, October 13, 2025 at 4:00:06 AM
PositiveFinancial Markets
Novo Nordisk’s ‘lottery ticket’: can obesity drugs help treat Alzheimer’s?
Novo Nordisk is exploring the potential of semaglutide, a drug typically used for obesity treatment, to also help those suffering from Alzheimer's disease. With results from two significant studies expected soon, this could be a groundbreaking development in the fight against Alzheimer's, offering hope to thousands of patients and their families. If successful, it may pave the way for new treatment options that address both obesity and cognitive decline, highlighting the interconnectedness of these health issues.
— Curated by the World Pulse Now AI Editorial System
Read Original

Was this article worth reading? Share it

Recommended Readings
Newman’s Own and Novo Nordisk have funded a program of Gen Z Native Americans who are fighting tribal food insecurity
Fortune6 hours ago
Newman’s Own and Novo Nordisk have funded a program of Gen Z Native Americans who are fighting tribal food insecurity
PositiveFinancial Markets
Newman's Own and Novo Nordisk have teamed up to support a program aimed at addressing food insecurity among Gen Z Native Americans. This initiative, organized by Native Americans in Philanthropy, empowers young participants aged 16 to 24 to engage in solutions that reflect the values of their communities. It's a significant step towards fostering self-sufficiency and resilience in tribal areas, highlighting the importance of inclusive approaches to tackling food challenges.
Read full article
via Fortune
Latest from Financial Markets
Apple TV Subtracts the + in a Quiet Rebrand
The New York Times29 minutes ago
Apple TV Subtracts the + in a Quiet Rebrand
NeutralFinancial Markets
Apple has decided to drop the '+' from its Apple TV branding, signaling a subtle rebranding effort. This change reflects the company's strategy to streamline its services and focus on enhancing user experience. As the streaming landscape becomes increasingly competitive, this move could help Apple clarify its offerings and strengthen its position in the market.
Read full article
via The New York Times
TD Cowen lowers Beyond Meat stock price target to $0.80 on dilution
Investing.com32 minutes ago
TD Cowen lowers Beyond Meat stock price target to $0.80 on dilution
NegativeFinancial Markets
TD Cowen has lowered its price target for Beyond Meat's stock to $0.80, citing concerns over dilution. This significant reduction reflects ongoing challenges for the plant-based meat company, which has struggled to maintain investor confidence amid increasing competition and market pressures. The adjustment in the stock price target is a critical indicator of the company's financial health and could influence investor decisions moving forward.
Read full article
via Investing.com
Erste Group initiates coverage on Ecolab stock with Buy rating
Investing.com32 minutes ago
Erste Group initiates coverage on Ecolab stock with Buy rating
PositiveFinancial Markets
Erste Group has started coverage on Ecolab stock, giving it a 'Buy' rating. This is significant as it reflects confidence in Ecolab's business model and growth potential, which could attract more investors and positively impact the stock's performance.
Read full article
via Investing.com
Erste Group upgrades Eli Lilly stock rating to Buy after strong H1 results
Investing.com32 minutes ago
Erste Group upgrades Eli Lilly stock rating to Buy after strong H1 results
PositiveFinancial Markets
Erste Group has upgraded its rating for Eli Lilly to 'Buy' following the company's impressive first half results. This upgrade reflects confidence in Eli Lilly's strong performance and growth potential, which is significant for investors looking for promising stocks in the pharmaceutical sector.
Read full article
via Investing.com
Erste Group downgrades AbbVie stock rating to Hold on guidance cut
Investing.com33 minutes ago
Erste Group downgrades AbbVie stock rating to Hold on guidance cut
NegativeFinancial Markets
Erste Group has downgraded AbbVie's stock rating to 'Hold' following a cut in the company's guidance. This decision reflects concerns about AbbVie's future performance and could impact investor confidence. Such downgrades often lead to fluctuations in stock prices, making it crucial for investors to stay informed about the company's outlook.
Read full article
via Investing.com
Financial Services Roundup: Market Talk
The Wall Street Journal33 minutes ago
Financial Services Roundup: Market Talk
NeutralFinancial Markets
The latest Market Talks provide valuable insights into the financial services sector, focusing on key developments such as the London Stock Exchange Group's performance, the third quarter results of Chinese banks, and updates from Blackstone. These insights are crucial for investors and analysts as they navigate the complexities of the market.
Read full article
via The Wall Street Journal